Physician profile
Robert J Blok
NPI 1497748552
$28,871.63
in general payments reported to CMS, 2019-2025
12 companies · $6,366 in 2025
The $6,366 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,753 · 2021: $892 · 2022: $72.32 · 2023: $2,801 · 2024: $6,871 · 2025: $6,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $1,184 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,500.00 |
| Food and Beverage | $1,183.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $355.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $26,568.59 | 2019-2025 | |
| Medtronic, INC. | $630.88 | 2021-2025 | Stealthstation S8 Platform, Anteralign Spinal System With Titan Nanolock Surface Technology, Catalyft Pl Expandable Interbody System |
| Alevio, LLC | $402.15 | 2019 | |
| Spinal Elements, INC. | $335.97 | 2019-2023 | |
| Si-Bone, INC. | $274.15 | 2021-2023 | |
| Surgalign Spine Technologies, INC. | $224.07 | 2019-2021 | |
| Spinal Surgical Strategies, INC. | $219.00 | 2020 | |
| Amgen INC. | $120.84 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $31.54 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $31.29 | 2025 | |
| Depuy Synthes Sales INC. | $17.92 | 2023 | Teligen |
| Pacira Pharmaceuticals Incorporated | $15.23 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$87,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Blok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.